EMVOSYS
Live / Applied — Third extension granted (statement of use) (as of 18 Mar 2026)
What this means for you
Not registered yet, but its 13 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97715626
- Mark type
- Stylized text
- Filed
- 13 Dec 2022
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of immuno-oncology preparations; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Anti-cancer preparations
Owner
- BioAtla, Inc., San Diego, CA, US
- BioAtla, Inc., San Diego, CA, US
Prosecution history
- 19 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Mar 2026 — SOU EXTENSION 3 GRANTED
- 18 Mar 2026 — SOU EXTENSION 3 FILED
- 18 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Aug 2025 — SOU EXTENSION 2 GRANTED
- 07 Aug 2025 — SOU EXTENSION 2 FILED
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 1 GRANTED
- 31 Mar 2025 — SOU EXTENSION 1 FILED
- 31 Mar 2025 — SOU TEAS EXTENSION RECEIVED